Seronegative generalised myasthenia gravis: clinical features, antibodies, and their targets.
Myasthenia gravis (MG) is a well-recognised disorder of neuromuscular transmission that can be diagnosed by the presence of antibodies to the acetylcholine receptor (AChR). However, some patients (about 15%) with generalised MG do not have detectable AChR antibodies. There is some evidence, however,...
Prif Awduron: | Vincent, A, Bowen, J, Newsom-Davis, J, McConville, J |
---|---|
Fformat: | Journal article |
Iaith: | English |
Cyhoeddwyd: |
2003
|
Eitemau Tebyg
-
Seronegative myasthenia gravis.
gan: Vincent, A, et al.
Cyhoeddwyd: (2004) -
Detection and characterization of MuSK antibodies in seronegative myasthenia gravis.
gan: McConville, J, et al.
Cyhoeddwyd: (2004) -
Detection of musk antibodies in seronegative myasthenia gravis using human musk as antigen
gan: McConville, J, et al.
Cyhoeddwyd: (2002) -
Anti-MuSK antibodies in seronegative myasthenia gravis: a cause of denervation
gan: Newsom-Davis, J, et al.
Cyhoeddwyd: (2001) -
Myasthenia gravis seronegative for acetylcholine receptor antibodies.
gan: Vincent, A, et al.
Cyhoeddwyd: (2008)